Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: A molecular dynamics study

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 9, 2011, Pages 2684-2692

  Monteiro Torres, Pedro Henrique ^a   Limaverde Soares Costa Sousa, Gabriel ^b   Pascutti, Pedro Geraldo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Angiogenesis; Cancer; Endostatin; Molecular dynamics; Peptide structure

Indexed keywords

ANGIOGENESIS INHIBITOR; CANSTATIN; COLLAGEN TYPE 4; ENDOSTATIN; INTEGRIN; METICRANE; ZINC;

ARTICLE; BINDING SITE; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; BINDING SITES; COLLAGEN TYPE IV; COLLAGEN TYPE XVIII; ENDOSTATINS; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STATIC ELECTRICITY;

MURINAE;

EID: 80051565429     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.23096     Document Type: Article

References (36)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
2. O'reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell Press 1997; 88: 277-285.
3. Oh SP, Kamagata Y, Muragaki Y, Timmons S, Ooshima A, Olsen BR. Isolation and sequencing of cDNAs for proteins with multiple domains of gly-xaa-yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci USA 1994; 91: 4229-4233.
4. Cattaneo MG, Pola S, Francescato PE, Chillemi F, Vicentini LM. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Exp Cell Res 2003; 283: 230-236.
5. Francescato P, Chillemi F, Rag E, Cattaneo MG, Pola S, Vicentini L. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. J Med Chem 2003; 46: 4165-4172.
6. Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M. Angiossupressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 2003; 9: 5358-5369.
7. Wickström SA, Alitalo K, Keski-Oja J. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migrtion of endothelial cells. J Biol Chem 2004; 279: 20178-20185.
8. 2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res 2005; 65: 3656-3653.
9. Becker CM, Sampson DA, Short SM, Javaherian K, Folkman J, D'amato RJ. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril 2006; 85: 71-77.
10. Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, Kinomura M, Sugiyama H, Makino H. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int 2005; 71: 227-238.
11. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407.
12. Sim BK, Fogler WE, Zhou XH, Liang HMadsen JW, Luu K, O'Reilly MS, Tomaszewski JE, Fortier AH. Zinc ligand-disrupted recombinant human endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile. Angiogenesis 1999; 3: 41-51.
13. Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR. Endostatin Inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO 1999; 18: 4414-4423.
14. Ding YH, Javaherian K, Lo KM, Chopra R, Boehm T, Lanciotti J, Harris BA, Li Y, Shapiro R, Hohenester E, Timpl R, Folkman J, Wiley DC. Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci USA 1998; 95: 10443-10448.
15. Hohenester E, Sasaki T, Mann K, Timpl R. Variable zinc coordination in endostatin. J Mol Biol 2000; 297: 1-6.
16. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000; 28: 235-242.
17. Delano WL, The pymol molecular graphics system. San Carlos, CA, USA: Delano Scientific; 2002. Available at:.
18. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. Gromacs: fast, flexible and free. J Comp Chem 2005; 26: 1701-1718.
19. Kabsch W, Sanders C. Dictionary of protein secondary structure: pattern recognition of hydrogen bonded and geometrical features. Biopolymers 1983; 22: 2577-2637.
20. Baker NA, Sept D, Joseph S, Holst MJ, Mccammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome Proc Natl Acad Sci USA 2001; 98: 10037-10041.
21. Kozakov D, Hall DR, Beglov D, Brenke R, Comeau SR, Shen Y, Li K, Zheng J, Vakili P, Paschalidis IC, Vajda S. Achieving reliability and high accuracy in automated protein docking: cluspro, piper, sdu, and stability analysis in Capri rounds 13-19. Proteins 2010; 78: 3124-3130.
22. Kozakov D, Brenke R, Comeau SR, Vajda S. Piper: an fft-based protein docking program with pairwise potentials. Proteins 2006; 65: 392-406.
23. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. Cluspro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004; 20: 45-50.
24. Comeau SR, Gatchell DW, Vajda S, Camacho CJ. Cluspro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 2004; 32 (Suppl 2): W96-W99.
25. Xiong XP, Mahalingham B, Alonso JL, Borrelli LA, Rui X, Anand S, Hyman BT, Rysiok T, Müller-Pompalla D, Goodman SL, Arnaout MA. Crystal structure of the complete integrin αvβ3 ectodomain plus an α/β transmembrane fragment. J Cell Biol 2009; 186: 589-600.
26. Than ME, Henrich S, Huber R, Ries A, Mann K, Kühn K, Timpl R, Bourenkov GP, Bartunik HD, Bode W. The 1.9-Å crystal structure of the noncollagenous (nc1) domain of human placenta collagen IV shows stabilization via a novel type of covalent met-lys cross-link. Proc Natl Acad Sci USA 2002; 99: 6607-6612.
27. Humphrey W, Dalke A, Schulten K. VMD-visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
28. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme PV, Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000; 60: 2520-2526.
29. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000; 275: 1209-1215.
30. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Xiao Y, Stillman IE, Kalluri R. Distinct antitumor properties of a type iv collagen domain derived from basement membrane. J Biol Chem 2000; 275: 21340-21348.
31. Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M, Kalluri R. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc Natl Acad Sci USA 2008; 105: 15040-15045.
32. He GA, Luo JX, Zhang TY, Wang FY, Li RF. Canstatin-n fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. BBRC 2003; 312: 801-805.
33. Nyberg P, Xie L, Sugimoto H, Colorado P, Sund M, Holthaus K, Sudhakar A, Salo T, Kalluri R. Characterization of the antia-angiogenic properties of arresten, an α1β1 integrin-dependent collagen-derived tumor suppressor. Exp Cell Res 2008; 314: 3292-3305.
34. Magnon C, Galaup A, Mullan B, Rouffiac V, Bidart JM, Griscelli F, Opolon P, Perricaudet M. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with αvβ3 and αvβ5 integrins. Cancer Res 2005; 65: 4353-4361.
35. Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S. Molecular interplay between endostatin, integrins and heparan sulfate. J Biol Chem 2009; 284: 22029-22040.
36. Xu HL, Tan HN, Wang FS, Tang W. Research advances of endostatin and its short internal fragments. Curr Prot Pept Sci 2008; 9: 275-283.